Spyre Therapeutics, Inc. (SYRE)
33.82
+0.14
(+0.42%)
USD |
NASDAQ |
Dec 10, 11:15
Spyre Therapeutics EPS Diluted (Quarterly): -0.184 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| PTC Therapeutics, Inc. | 0.195 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.18M |
| Total Expenses (Quarterly) | 11.18M |
| Enterprise Value | 2.127B |
| Earnings Yield | -6.44% |
| Normalized Earnings Yield | -7.878 |